Radiotherapy Treatment to Brain Tumor
Keywords:
Brain Tumor, Chemotherapy, Radiobiological, ImmunotherapyAbstract
A group of abnormal brain cells known as a brain tumor. A brain tumor is an abnormal enlargement of the brain's surrounding tissue. To improve treatment options and increase patient survival rates, early brain tumor identification is essential. It is essential to diagnose and treat brain tumors as soon as possible to avoid irreversible brain damage or the patient's death. Brain tumors can either be malignant or benign. Should a brain tumor become large enough to compress nerves, blood vessels, and other tissues, it may affect brain function. Just one-third of brain tumors started out as malignant cells. Surgery, radiation therapy, and targeted therapy are available for the treatment of brain tumors. Sixty-seven percent of cancer patients receive radiotherapy, and only a relatively small percentage of those individuals receive charged particle therapy. One potential brain tumor inhibitor that may be utilized to treat advanced cancers is being discovered. The purpose of this review is to provide comprehensive information about brain tumors, including diagnosis, treatment options, risk factors, and related symptoms. The therapy of brain tumors is discussed from a radiobiological standpoint in this review.
Downloads
References
Raghavapudi H, Singroul P, Kohila V. Brain tumor causes, symptoms, diagnosis and radiotherapy treatment. Current Medical Imaging. 2021 Aug 1;17(8):931-42.
Schnegg CI, Robbins ME. Neuroprotective mechanisms of PPARδ: Modulation of oxidative stress and inflammatory processes. PPAR research. 2011;2011(1):373560.
Blumenthal DT, Cannon-Albright LA. Familiality in brain tumors. Neurology. 2008 Sep 23;71(13):1015-20.
Caffo M, et.al, (2022). Medically reviewed by Seunggu Han, M.D. By Verneda Lights Updated on March 17,1
Jayalakshmi K, Prabha MS, Baburao CH, Shobana G, Kumari KR. BRAIN TUMOR METHOD OF TREATMENT.
Perkins A, Liu G. Primary brain tumors in adults: diagnosis and treatment. American family physician. 2016 Feb 1;93(3):211-7B.
Anvari K, Bahadorkhan G, Samini F, Izadpanahi P, Bayatmokhtari N, Javadinia SA. Pathological diagnostic pitfalls in the verification of brain tumors; can imaging lead to pathology alternation?. Reports of Radiotherapy and Oncology. 2015 Dec 31;2(4).
Vennela, B; Shirisha, V; Rao, Chandu Babu; Gullapalli, Venkatesh; Batsala, Mahesh; Current and Future Strategies for Therapy of Pancreatic Cancer International Journal of Research in Pharmacy and Medicine 23728-740 2012
Muldoon LL, Soussain C, Jahnke K, Johanson C, Siegal T, Smith QR, Hall WA, Hynynen K, Senter PD, Peereboom DM, Neuwelt EA. Chemotherapy delivery issues in central nervous system malignancy: a reality check. Journal of clinical oncology. 2007 Jun 1;25(16):2295-305.
Dropcho EJ, Rosenfeld SS, Vitek J, Guthrie BL, Morawetz RB. Phase II study of intracarotid or selective intracerebral infusion of cisplatin for treatment of recurrent anaplastic gliomas. Journal of neuro-oncology. 1998 Jan;36:191-8.
Chowdary KP, Chandra DU, Mahesh N, Reddy TM, Gopaiah KV. Enhancement of dissolution rate and formulation development of pioglitazone-a BCS class II drug. J. Pharm. Res. 2011 Nov;4:3862-3.
Remsen LG, Trail PA, Hellström I, Hellström KE, Neuwelt EA. Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model. Neurosurgery. 2000 Mar 1;46(3):704-9.
Remsen LG, Trail PA, Hellström I, Hellström KE, Neuwelt EA. Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model. Neurosurgery. 2000 Mar 1;46(3):704-9.
Sheleg SV, Korotkevich EA, Zhavrid EA, Muravskaya GV, Smeyanovich AF, Shanko YG, Yurkshtovich TL, Bychkovsky PB, Belyaev SA. Local chemotherapy with cisplatin-depot for glioblastoma multiforme. Journal of neuro-oncology. 2002 Oct;60:53-9.
Sheleg SV, Korotkevich EA, Zhavrid EA, Muravskaya GV, Smeyanovich AF, Shanko YG, Yurkshtovich TL, Bychkovsky PB, Belyaev SA. Local chemotherapy with cisplatin-depot for glioblastoma multiforme. Journal of neuro-oncology. 2002 Oct; 60:53-9.
Yoshida J, Mizuno M. Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma. Journal of Neuro-oncology. 2003 Dec; 65:261-7.
Pisipati SV, Pathapati H, Bhukya G, Nuthakki S, Chandu B, Nama S, Adeps R. Lycopene: Redress for prostate cancer. Journal of Basic and Clinical Pharmacy. 2012 Mar;3(2): 261.
.P. Kleihues, The new WHO classification of brain tumor,“brain pathology, vot3, pp255-268, 1993
Jelski W, Mroczko B. Molecular and circulating biomarkers of brain tumors. International journal of molecular sciences. 2021 Jun 29;22(13):7039.
Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. Journal of Cell Biology. 2011 Feb 7;192(3):373-82.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
